Observational studyBritish journal of haematology2018

Efficacy of retreatment with immunomodulatory drugs and proteasome inhibitors following daratumumab monotherapy in relapsed and refractory multiple myeloma patients.

Rimke Oostvogels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.